Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Psychemedics Corporation as of December 31, 2024 is 19.68 MM.
- The operating income for Psychemedics Corporation as of December 31, 2024 is -1.89 MM.
- The net income for Psychemedics Corporation as of December 31, 2024 is -1.86 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2024-12-31 | 19.68 | -1.89 | -1.86 |
2024-09-30 | 20.26 | -2.93 | -3.00 |
2024-06-30 | 20.79 | -3.44 | -4.56 |
2024-03-31 | 21.60 | -2.96 | -4.46 |
2023-12-31 | 22.10 | -2.92 | -4.15 |
2023-09-30 | 22.80 | -2.41 | -3.90 |
2023-06-30 | 23.61 | -1.68 | -1.90 |
2023-03-31 | 24.59 | -1.60 | -1.51 |
2022-12-31 | 25.24 | -1.08 | -1.08 |
2022-09-30 | 25.97 | -1.69 | -2.02 |
2022-06-30 | 26.13 | -0.47 | -1.18 |
2022-03-31 | 25.70 | 0.08 | -0.71 |
2021-12-31 | 24.91 | 0.21 | -0.67 |
2021-09-30 | 23.81 | 0.07 | 0.41 |
2021-06-30 | 22.31 | -2.19 | -1.43 |
2021-03-31 | 19.54 | -5.71 | -3.62 |
2020-12-31 | 21.36 | -6.07 | -3.86 |
2020-09-30 | 24.74 | -4.76 | -3.85 |
Income Statement: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Psychemedics Corporation as of December 31, 2024 is 0.93 MM.
- The cash from investing activities for Psychemedics Corporation as of December 31, 2024 is -0.09 MM.
- The cash from financing activities for Psychemedics Corporation as of December 31, 2024 is -1.39 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2024-12-31 | 0.93 | -0.09 | -1.39 |
2024-09-30 | 0.57 | 0.04 | -0.58 |
2024-06-30 | -0.65 | -0.01 | -0.36 |
2024-03-31 | -1.73 | -0.08 | -1.15 |
2023-12-31 | -1.48 | -0.16 | -1.15 |
2023-09-30 | -0.25 | -0.18 | -1.66 |
2023-06-30 | 3.04 | -0.24 | -2.15 |
2023-03-31 | 4.32 | -0.24 | -1.82 |
2022-12-31 | 4.89 | -0.21 | -1.92 |
2022-09-30 | 3.56 | -0.21 | -1.86 |
2022-06-30 | 0.84 | -0.23 | -1.47 |
2022-03-31 | 1.17 | -0.20 | -1.04 |
2021-12-31 | 0.41 | -0.22 | -1.03 |
2021-09-30 | 0.99 | -0.14 | -0.69 |
2021-06-30 | -0.12 | -0.26 | -0.68 |
2021-03-31 | -4.08 | -0.58 | 1.49 |
2020-12-31 | -4.08 | -0.86 | 0.50 |
2020-09-30 | -4.28 | -1.48 | 0.99 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2024-12-31 | |||
2024-09-30 | -2.98 | 2.36 | 2.36 |
2024-06-30 | -3.09 | 2.19 | 2.19 |
2024-03-31 | 2.65 | 2.65 | |
2023-12-31 | -4.47 | 2.34 | 2.34 |
2023-09-30 | -12.03 | 2.50 | 2.50 |
2023-06-30 | -17.17 | 2.54 | 2.54 |
2023-03-31 | -27.53 | 2.77 | |
2022-12-31 | -13.73 | 2.36 | 2.36 |
2022-09-30 | 3.04 | 3.04 | |
2022-06-30 | 2.80 | 2.80 | |
2022-03-31 | -57.51 | 3.12 | 3.12 |
2021-12-31 | 94.20 | 2.77 | 2.77 |
2021-09-30 | -32.49 | 3.55 | 3.55 |
2021-06-30 | |||
2021-03-31 | -9.95 | 2.81 | 2.81 |
2020-12-31 | -9.33 | 2.88 | 2.88 |
2020-09-30 | -9.34 | 2.78 | 2.78 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2024-12-31 | ||
2024-09-30 | -0.27 | -0.24 |
2024-06-30 | -0.28 | -0.16 |
2024-03-31 | -0.21 | -0.11 |
2023-12-31 | -0.18 | -0.11 |
2023-09-30 | -0.11 | -0.09 |
2023-06-30 | -0.07 | -0.08 |
2023-03-31 | -0.04 | -0.10 |
2022-12-31 | -0.11 | -0.11 |
2022-09-30 | -0.04 | -0.07 |
2022-06-30 | -0.03 | -0.06 |
2022-03-31 | -0.02 | -0.04 |
2021-12-31 | 0.00 | -0.03 |
2021-09-30 | -0.05 | -0.02 |
2021-06-30 | ||
2021-03-31 | -0.15 | 0.02 |
2020-12-31 | -0.17 | 0.04 |
2020-09-30 | -0.15 | 0.07 |
Management Effectiveness
- The roa for Psychemedics Corporation as of December 31, 2024 is -0.15.
- The roe for Psychemedics Corporation as of December 31, 2024 is -0.28.
- The roic for Psychemedics Corporation as of December 31, 2024 is -0.29.
- The croic for Psychemedics Corporation as of December 31, 2024 is -0.09.
- The ocroic for Psychemedics Corporation as of December 31, 2024 is 0.15.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2024-12-31 | -0.15 | -0.28 | -0.29 | -0.09 | 0.15 |
2024-09-30 | -0.32 | -0.61 | -0.60 | -0.13 | -0.09 |
2024-06-30 | -0.25 | -0.44 | -0.54 | -0.36 | -0.21 |
2024-03-31 | -0.22 | -0.39 | -0.46 | -0.31 | -0.16 |
2023-12-31 | -0.19 | -0.33 | -0.39 | -0.21 | -0.02 |
2023-09-30 | -0.09 | -0.16 | -0.16 | 0.05 | 0.25 |
2023-06-30 | -0.07 | -0.13 | -0.16 | 0.05 | 0.25 |
2023-03-31 | -0.05 | -0.09 | -0.11 | 0.17 | 0.32 |
2022-12-31 | -0.09 | -0.14 | -0.13 | 0.10 | 0.23 |
2022-09-30 | -0.05 | -0.08 | -0.13 | 0.09 | 0.23 |
2022-06-30 | -0.03 | -0.05 | -0.07 | -0.05 | 0.05 |
2022-03-31 | -0.03 | -0.05 | -0.04 | -0.00 | 0.07 |
2021-12-31 | 0.02 | 0.03 | -0.04 | -0.05 | 0.05 |
2021-09-30 | 0.02 | -0.11 | 0.02 | 0.01 | -0.01 |
2021-06-30 | -0.06 | -0.10 | -0.07 | -0.05 | -0.01 |
2021-03-31 | -0.14 | -0.23 | -0.17 | -0.15 | -0.19 |
2020-12-31 | -0.14 | -0.23 | -0.18 | -0.21 | -0.19 |
2020-09-30 | -0.14 | -0.21 | -0.17 | -0.21 | -0.19 |
Gross Margins
- The gross margin for Psychemedics Corporation as of December 31, 2024 is 0.36.
- The net margin for Psychemedics Corporation as of December 31, 2024 is -0.09.
- The operating margin for Psychemedics Corporation as of December 31, 2024 is -0.10.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2024-12-31 | 0.36 | -0.09 | -0.10 |
2024-09-30 | 0.38 | -0.22 | -0.17 |
2024-06-30 | 0.39 | -0.21 | -0.14 |
2024-03-31 | 0.38 | -0.19 | -0.13 |
2023-12-31 | 0.30 | -0.17 | -0.18 |
2023-09-30 | 0.30 | -0.08 | -0.15 |
2023-06-30 | 0.30 | -0.08 | -0.15 |
2023-03-31 | 0.37 | -0.06 | -0.14 |
2022-12-31 | 0.36 | -0.08 | -0.07 |
2022-09-30 | 0.38 | -0.08 | -0.07 |
2022-06-30 | 0.39 | -0.05 | -0.02 |
2022-03-31 | 0.41 | -0.03 | 0.00 |
2021-12-31 | 0.39 | -0.03 | 0.01 |
2021-09-30 | 0.33 | 0.02 | 0.00 |
2021-06-30 | 0.33 | -0.06 | -0.10 |
2021-03-31 | 0.24 | -0.19 | -0.29 |
2020-12-31 | 0.23 | -0.18 | -0.28 |
2020-09-30 | 0.29 | -0.16 | -0.19 |
Identifiers and Descriptors
Central Index Key (CIK) | 806517 |
Industry Groups
SIC 8071 - Medical Laboratories |